Background Recent clinical trials have demonstrated the efficacy of mechanical
thrombectomy in acute ischemic stroke. Aims To determine the cost-effectiveness, value of …

Object Mechanical thrombectomy is increasingly being used for the treatment of large-vessel
ischemic stroke in patients who arrive outside of the 3-hour tissue plasminogen activator …

Background and Purpose—Recently, 5 randomized controlled trials demonstrated the
benefit of endovascular therapy compared with intravenous tissue-type plasminogen …

Although intravenous thrombolysis increases the probability of a good functional outcome in
carefully selected patients with acute ischemic stroke, a substantial proportion of patients …

Background: The beneficial effects of endovascular treatment with new-generation
mechanical thrombectomy devices compared with intravenous thrombolysis alone to treat …

Purpose Although good evidence exists regarding the clinical effectiveness of mechanical
thrombectomy for people with acute ischaemic stroke, cost-effectiveness should also be …

Background Recently, two randomized controlled trials demonstrated the benefit of
mechanical thrombectomy performed between 6 and 24 h in acute ischemic stroke. The …

Background In Ontario, current treatment for eligible patients who have an acute ischemic
stroke is intravenous thrombolysis (IVT). However, there are some limitations and …

Stroke remains a major worldwide threat to health despite substantial improvements in both
prevention and treatment in recent years. In Western countries, ischaemic stroke due to …

The original version of this consensus statement on mechanical thrombectomy was
approved at the European Stroke Organisation (ESO)-Karolinska Stroke Update conference …